The regulation of cholesterol via the LDL-receptor (LDLR) pathway featuring receptor-mediated endocytosis was recognised as critical to atherosclerosis [16] and this facilitated the identification of genetic defects that cause malfunction of the LDL receptor as a major risk factor [17]. Here, LDLR is linked to atherosclerosis.